AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India
· Delayed Price · Currency is INR 8,674.00
+73.00 (0.85%)
Mar 6, 2026, 3:30 PM IST
AstraZeneca Pharma India Company Description
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.
The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.
AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Limited
| Country | India |
| Founded | 1979 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 600 |
| CEO | Praveen Akkinepally |
Contact Details
Address: Manyata Embassy Business Park Bengaluru, 560045 India | |
| Phone | 91 80 6774 8000 |
| Website | astrazeneca.in |
Stock Details
| Ticker Symbol | ASTRAZEN |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE203A01020 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bhavana Agrawal | Whole-Time Director and Chief Financial Officer |
| Praveen Rao Akkinepally | MD and Director |
| Pankaj S Jain | Legal Head |
| Tanya Sanish | Company Secretary and Compliance Officer |
| Smita Saha | Vice President of Human Resources |
| Ayush Kumar Agarwal | Business Unit Head of Biopharmaceutical Business Unit |
| Vinay Sharma | Business Unit Head - Rare Disease unit |
| Amarpreet Kaur Ahuja | Country Human Resources Director |
| Srikanth B. S. | Site Lead, India Operations |